Keywords
Sustainable Development Goals, Outbreak response, Universal Health Coverage, Operational Research, SORT IT
This article is included in the Emerging Diseases and Outbreaks gateway.
This article is included in the TDR gateway.
This article is included in the Ebola Virus collection.
Sustainable Development Goals, Outbreak response, Universal Health Coverage, Operational Research, SORT IT
We have made some minor edits to formatting and grammar. In addition, in response to reviewers, we have added clarifications in the introductory paragraph on recovery or improvement. We added t-tests to the methods description and disaggregated the analysis of monthly consultation trends across time periods by disease condition. Therefore, Figure 1 now has four components, one for each of the conditions. We added in Table 1 which presents the results of the t-tests for differences in mean monthly consultations for the four conditions. Finally, in the discussion section, we added points on lack of representation in our data and findings of longer term changes in the health system; a description of our finding on the reductions in case fatality from malaria, ARI/pneumonia and watery diarrhoea; an elaboration on the possible explanations for the decline in immunization services; as well as recommendations for future research.
See the authors' detailed response to the review by Sara Hersey
See the authors' detailed response to the review by Justin Lessler
In 2017, a cross-sectional study1 documented country-wide morbidity for four common childhood illnesses: malaria, acute respiratory infections (ARI)/pneumonia, watery diarrhoea and measles. There were two main findings. First, during the Ebola outbreak, health facility visits for malaria, ARI/pneumonia and watery diarrhoea dropped significantly nation-wide, without returning to pre-Ebola levels post-outbreak. As these morbidities have similar symptom patterns as Ebola, people may have avoided accessing formal health services to avoid being considered “an Ebola case”. Second, measles cases increased dramatically by six-fold during Ebola and the immediate post-Ebola periods. This was attributed to cessation of measles vaccination activities during the Ebola outbreak.
The outbreak was declared over in November 2015. Since then, there have been considerable investments into the health system by Government and development partners. One of the limitations of the 2017 study1 was that it only included the immediate six-month period after the Ebola outbreak, which might have been too early to assess health system recovery or possible improvement. It is now expected that the country would have fully recovered from the outbreak, but there has been no formal evaluation in this regard.
We thus conducted a similar country-wide study assessing morbidity and mortality for the same childhood illnesses using a longer post-Ebola period and compared this data with the pre- and intra Ebola periods.
This was a retrospective analysis using routine program data from the District Health Information system (DHIS2) and sourced from all 14 districts in Sierra Leone (see Underlying data2).
The study setting was described in detail before1. In brief, the health infrastructure is tiered into tertiary hospitals, district hospitals and Peripheral Health Units (PHUs). PHUs include Community Health Centres (CHCs), Community Health Posts (CHPs) and Maternal and Child Health Posts (MCHPs). The Ministry of Health and Sanitation provides free primary health care for children under five across 1,250 health facilities nationwide.
The study population included all children under-five years attending public health facilities nationwide. No children were excluded.
Study periods included: before (June 1st 2013-April 30th 2014); during (June 1st 2014-April 30th 2015); and after Ebola (June 1st 2016-April 30th 2017).
We exported data on health facility visits and mortality for malaria, ARI/pneumonia, watery diarrhoea and measles from the DHIS2 to Microsoft excel (2016) for analysis. Differences between groups were assessed using Pearson’s X2 test (Chi square) for the case fatality and t-tests for the average monthly consultations. Levels of significance were set at P ≤ 0.05.
Ethics approval was obtained from the Sierra Leone Ethics and Scientific Review Board (dated 14 December 2018) and the Union Ethics Advisory Group (International Union against Tuberculosis and Lung Disease, Paris, France; EAG number: 68/18). As the study used anonymous data, there was no need for informed consent.
Figure 1 shows country-wide trends in outpatient consultations for malaria, ARI/pneumonia, watery diarrhoea and measles. Consultations followed a seasonal pattern with an overall decline during Ebola. In the post-Ebola period (assessed six months after the end of the outbreak), consultations reached pre-Ebola levels. In contrast, measles increased during the last six months of the Ebola outbreak and this trend continued into the post-Ebola period. Average numbers of measles cases were 48/month in the pre-Ebola period, increasing to 87/month in the Ebola period and 568/month (12-fold increase) post-Ebola. Measles cases peaked in March 2017 with 853 cases.
a): Malaria consultations in the pre-Ebola, intra-Ebola and post-Ebola periods. b) ARI/Pneumonia consultations in the pre-Ebola, intra-Ebola and post-Ebola periods. c) Watery diarrhea consultations in the pre-Ebola, intra-Ebola and post-Ebola periods. d) Measles consultations in the pre-Ebola, intra-Ebola and post-Ebola periods.
Table 1 shows that the observed differences of the pre-Ebola period relative to both the intra-Ebola and post-Ebola periods were statistically significant for all morbidities.
Table 2 shows numbers of cases, deaths and case-fatality (per 1,000) for malaria, ARI/pneumonia, watery diarrhoea and measles. During the post-Ebola period, there was a highly significant reduction in case-fatality for the first three morbidities compared to the pre-Ebola period (P<0.0001).
Pre-Ebola | Ebola | Post-Ebola | P-value2 | |
---|---|---|---|---|
n | n | n | ||
Malaria | ||||
Cases | 989,068 | 724,881 | 1056354 | |
Deaths | 2,564 | 1,205 | 2,112 | |
Deaths/1000 | 2.6 | 1.7 | 2.0 | <0.0001 |
ARI/Pneumonia | ||||
Cases | 717,345 | 521,860 | 735,836 | |
Deaths | 849 | 794 | 568 | |
Deaths/1000 | 1.2 | 1.5 | 0.8 | <0.0001 |
Watery Diarrhoea | ||||
Cases | 200,006 | 124,100 | 203,520 | |
Deaths | 361 | 150 | 242 | |
Deaths/1000 | 1.8 | 1.2 | 1.2 | <0.0001 |
Measles | ||||
Cases | 525 | 962 | 6,245 | |
Deaths | 1 | 16 | 6 | |
Deaths/1000 | 1.9 | 16.6 | 1.0 | 0.5 |
For measles, there was a total of 525 cases pre-Ebola, 962 cases during Ebola and 6,245 cases post-Ebola. Although there was no difference in measles case-fatality between the pre- and post-Ebola periods, case-fatality post-Ebola was significantly lower than during Ebola (Relative Risk: 0.05, 95% confidence interval 0.02–0.15, P<0.0001).
This study shows that health facility consultations for malaria, ARI/Pneumonia and watery diarrhoea recovered to pre-Ebola levels and were accompanied by significant country-wide reductions in case-fatality compared to the pre-Ebola period. Despite a dramatic increase in measles cases post-Ebola, there was a significant mortality reduction, suggesting overall improvements in clinical care.
A study strength is that we included data from 1,250 health facilities and for similar periods before, during and after the outbreak. A limitation is that our data did not include private health facilities resulting in possible underestimation of disease burden. In addition, our post-Ebola period was limited to 2017, which may not be representative of long-term changes in systems strengthening.
There were two key findings. First, the reductions in case fatality from malaria, ARI/pneumonia and watery diarrhoea could be associated with post- Ebola health system investments with improved health seeking behaviour. The post-Ebola recovery plan3 of the Government of Sierra Leone with enhanced financial, technical and training support from partners may also have contributed. Furthermore, community health worker activities including early identification and referrals of ill children were promoted which in turn would contribute to reducing mortality.
Second, increased measles cases during and after Ebola could be attributed to vaccination service cessation during Ebola in line with the recommendation to avoid invasive procedures as a way of minimizing Ebola-related occupational risks4. Many children would have missed their measles vaccination, resulting in a reduction in herd immunity as well as an accumulation of unvaccinated children. Measles coverage among children under two years in 2017 (post-Ebola) stood at 80%5 while pre-Ebola this was at a low 78.6%6. This implies that measles vaccination coverage was already below the desired level prior to Ebola, worsened during Ebola and remained below desired levels after Ebola. The decline in immunization services during the Ebola period may have triggered a measles outbreak; however the resumption of immunization services would have contributed to the reduction of the cases in the post-Ebola period. This calls for strategies to increase immunisation coverage to at least 95%7,8 and to increase in the coverage of the second measles dose taken at 15 months of age.
Future research may consider including additional time periods of 2018-2019 to understand the longer term changes of health systems strengthening efforts on service delivery.
In conclusion, consultations of under-five children at health facilities in Sierra Leone recovered to pre-Ebola levels and case-fatality for common childhood illnesses declined significantly. This is a change for the better. However, the high level of reported measles cases in the post-Ebola period needs focused attention.
The Sierra Leone Health Management Information Systems, the District Health Information System 2 (DHIS2), is accessible with a Ministry of Health and Sanitation (MOHS) login through https://sl.dhis2.org/. The Directorate of Policy, Planning, and Information (DPPI) can be contacted to arrange access through Dr. Francis Smart (drfsmart@gmail.com), Director, DPPI, MOHS.
Repository: Dataset 1. Sesay_Tom_SORTIT2_paed_data. https://doi.org/10.17605/OSF.IO/SYP7G2
This project contains the following underlying data:
Sesay_T_casefatality_data.xlsx (case fatality data)
Sesay_T_morbidity_data.xlsx (morbidity data)
Sesay_T_paed_datadictionary.xlsx (data dictionary)
Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership coordinated by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and implemented with partners. The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medécins sans Frontières (MSF). The specific SORT IT programme which resulted in this publication was jointly developed and implemented by: WHO/TDR, the Sierra Leone Ministry of Health and Sanitation, WHO Sierra Leone and the Centre for Operational Research, The Union, Paris, France, Alliance for Public Health, Ukraine; Institute of Tropical Medicine, Antwerp, Belgium; and Sustainable Health Systems, Freetown, Sierra Leone.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
References
1. Aregawi M, Smith SJ, Sillah-Kanu M, Seppeh J, et al.: Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone.Malar J. 2016; 15: 480 PubMed Abstract | Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: infectious diseases
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Infectious Diseases
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: I taught with Rony Zachariah in November 2019 in Nepal on a one week SORT IT course. I have not had social contact with him before or after.
Reviewer Expertise: Public Health, Health Protection, Environmental public health, Iodine deficiency.
Competing Interests: No competing interests were disclosed.
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Epidemiology, statistics, infectious disease dynamics
Is the work clearly and accurately presented and does it cite the current literature?
Partly
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Infectious disease epidemiology
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
Version 2 (revision) 09 Jan 20 |
read | read | read | read | read | |
Version 1 06 Jun 19 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)